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Objectives: Shift work is associated with several negative health effects. The
underlying pathophysiological mechanisms are unclear, but low-grade inflammation
has been suggested to play a role. This project aimed to determine whether levels
of immunological biomarkers differ depending on work schedule, self-reported sleep
duration, self-reported sleep quality, and presence of shift work disorder (study 1).
Furthermore, we aimed to determine whether these biomarkers differ after a night of
sleep vs. at the end of a night or a day shift (study 2).
Methods: In study 1, 390 nurses provided blood samples after a night of sleep
with the dried blood spot method. In study 2, a subset of 55 nurses also provided
blood samples after a day shift and after a night shift. The following biomarkers were
measured: interleukin-1alpha, interleukin-1beta, interleukin-4, interleukin-6, interleukin-8,
interleukin-10, interleukin-13, monocyte chemoattractant protein-1, interferon-gamma,
and tumor necrosis factor-alpha. Multiple linear regressions with adjustment for age,
sex and body mass index (study 1) and ANOVAs with repeated measures (study 2)
were conducted.
Results: In study 1, neither work schedule, number of night shifts, number of quick
returns (<11 h between consecutive shifts), sleep duration, poor sleep quality, nor shift
work disorder were systematically associated with most of these biomarkers. Compared
with day only work, day-evening work was associated with higher levels of IL-1alpha and
IL-13, quick returns were associated with higher levels of IL-1beta and MCP-1, short
sleep duration (<6 h) was associated with lower levels of IL-1beta and higher levels of
TNF-alpha, and long sleep duration (8+ h) was associated with higher levels of IL-13. In
study 2, IL-1beta levels were higher (large effect size) both after a day shift (14% increase)
and a night shift (75% increase) compared with levels after a night of sleep. Similarly,
TNF-alpha levels were higher (moderate-large effect size) after a day shift (50% increase)
compared to after a night of sleep. In contrast, MCP-1 levels were lower (large effect size)
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both after a day shift (22% decrease) and a night shift (12% decrease) compared with
after a night of sleep.
Conclusions: We found some indications that shift work influenced immunological
biomarkers. The results should be interpreted with caution due to limitations, e.g., related
to the sampling procedure and to low levels of biomarkers in the blood samples.
Keywords: shift work disorder, immunity, inflammatory biomarkers, cytokines, interleukin, tumor necrosis
factor-alpha, monocyte chemoattractant protein-1, blood spot method
INTRODUCTION
Shift work is associated with a number of negative health
effects, e.g., cardiovascular disorders and cancer (1, 2). Still,
the underlying pathophysiological mechanisms are unclear.
However, several studies suggest that low-grade inflammation
may play a role. Both short sleep and sleep disturbances are
associated with increased levels of pro-inflammatory biomarkers
such as interleukin-1 (IL-1), interleukin-6 (IL-6) and tumor
necrosis factor (TNF) (3, 4). Despite short sleep and sleep
disturbances being common amongst shift workers (1), there is
dearth of studies investigating the association between shift work
and immunological biomarkers.
Studies investigating the link between shift work and
immunity are few and show conflicting results. In a cross-
sectional study among airline employees, Puttonen et al. (5)
found that rotating shift work was associated with increased
systemic inflammation. In a longitudinal study among 68 nurses
with shift work and 28 nurses with daytime work, IL-1beta
and TNF-alpha were significantly lower among shift workers
at baseline, but not at 12 months follow-up. Furthermore, no
effect of shift work on immunological biomarkers was present
at 12 months follow-up when baseline values and job seniority
were adjusted for (6). Another study among nurses showed that
natural killer (NK) cell activity was reduced following night work
compared to day work (7). Furthermore, a study comparing
day workers with rotating shift workers showed higher levels of
leucocytes in the latter group (8). The authors suggested that
this reflected systemic inflammation, but since leukocyte levels
vary extensively across time of day (9), it may also be attributed
to group differences in circadian phase at the time of sampling.
When comparing 225 shift workers with 137 day workers, no
differences in IL-6, TNF-alpha, or lymphocyte count were found
(10). Also, in a recent study comparing 254 night shift workers
with 57 non-shift workers, no association in relation to work
status was detected on a range of cytokines. However, night
work was associated with increased number of monocytes and
lymphocytes (11). In a clinical review, Faraut et al. (12) addressed
the issue of shift work and immunity, and suggested several lines
of further studies (e.g., use of non-invasive biological markers,
conduct more longitudinal studies) to delineate the pathways
by which circadian misalignment and short sleep may influence
immunological mechanisms.
Much of the literature concerning sleep and shift work
has focused on pro-inflammatory cytokines such as IL-1, IL-6,
and TNF-alpha. However, the immune system serves many
other functions, and there is a need to measure additional
immunological biomarkers to better understand whether the
interplay and complexity of immune functions are involved
in how shift work may affect health outcomes. For example,
there is limited knowledge about how shift work affects anti-
inflammatory cytokines, such as IL-4 and IL-10, or other
cytokines, such as IL-13 and interferon (IFN), which may have
sleep regulatory properties (4). One complicating issue when
studying healthy humans is that the blood concentrations of most
cytokines are very low, and often not detectable (4).
In the present project, we collected blood from shift working
nurses using the dried blood spot technique (13). This is a
minimally invasive method in which blood may be collected at
home or at the workplace, and by the participants themselves.
This blood collection technique analyzed with quantitative
antibody array technology allows for quantification of several
cytokines from the same sample. By using this technique, we
were able to quantify the following immunological biomarkers:
IL-1alfa, IL-1beta, IL-4, IL-6, IL-8, IL-10, IL-13, monocyte
chemoattractant protein (MCP)-1, IFN-gamma, and TNF-alpha.
This project consists of two studies, with two different aims.
Aim of study 1: To determine whether levels of immunological
biomarkers differ between nurses (n = 390) (a) on different
shift schedules, (b) working different number of night shifts, (c)
working different number of quick returns (defined as <11 h
between consecutive shifts), (d) with short or long vs. normal
self-reported sleep duration and (e) with good vs. poor self-
reported sleep quality. Furthermore, (f) to determine whether
levels of immunological biomarkers differ between nurses with
and without shift work disorder. Aim of study 2: In nurses
rotating between night and day work (n = 55), determine
whether levels of immunological biomarkers differ after a night
of sleep compared with levels after a night shift (both blood
samples taken at about the same time) and after a day shift (blood
sample taken at about 3 p.m.). Using these within-subject data,




Nurses were asked if they wanted to participate in this
immunological project when completing a questionnaire in the
ongoing cohort study “SUrvey of Shift work, Sleep, and Health
(SUSSH)” (14). In the first immunological project (study 1),
485 nurses received the necessary equipment and instructions
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for sampling blood using the blood spot technique by postal
mail. Only nurses who were working either day shifts only,
a two-rotational schedule (day and evening shifts) or a three-
rotational schedule (day, evening, and night shifts) were invited
to participate. They were asked to take fasting blood samples
when waking up the morning after a night of sleep, but before
the start of the day shift. The participants were instructed
to refrain from taking and sending samples if they had been
ill or experienced fever during the last 3 days. Furthermore,
nurses were asked not to take samples if they were pregnant.
A total of 375 nurses returned blood samples together with
a short questionnaire in which they answered questions about
sleep duration and sleep quality (very good, pretty good,
indifferent, pretty bad, and very bad) the night before blood
sampling. Thus, response rate was 77.3%. Due to poor quality
of some blood samples (insufficient magnitude; 224 samples)
and missing questionnaires (4 samples), 228 nurses were sent
new blood sample equipment and questionnaire. Still, not all
nurses provided satisfactory blood samples, and the final number
of samples with sufficient quality for analyses was 334. All
nurses who participated in study 1 received a compensation of
about EUR 40.
In study 2, 99 nurses working three-rotational shifts were sent
blood sampling equipment. Besides the fasting blood samples
taken in the morning after a night of sleep, these nurses also
provided non-fasting blood samples right after the following day
shift (at about 3 p.m.) and immediately after a night shift (taken
at about the same time as the blood sample after a night of sleep).
These nurses were also instructed not to take any samples if being
ill or having fever during the last 3 days, as well as not taking
samples if they were pregnant. Sixty-four nurses returned the
blood samples together with a similar questionnaire as in study 1,
in which the nurses answered questions about sleep duration and
sleep quality the night before the first blood sample. Response
rate was 64.6% in this study. Due to poor quality of some of the
blood samples (27 samples) or lack of completed questionnaire
(1 sample), 28 nurses were sent new blood sample equipment
and questionnaire. Still, some of the samples had poor quality,
resulting in data from a total of 56 participants having three
samples each to be analyzed. One participant was excluded from
the within-subject analyses due to sleeping during the night shift.
Sample 1 from the 56 participants in study 2 was included with
the samples in study 1, as all these samples were taken in the
morning after a night of sleep. Each nurse in study 2 received
a compensation of about EUR 100.
The most common work hours for the Norwegian nursing
population are 07:00–15:00 (day shifts), 14:30–22:00 (evening
shifts), and 22:00–07:30 (night shifts). Nurses working in
outpatient clinics or administratively may work 08:00–16:00.
Shift workers have a 35.5 h workweek, while day workers have
a 37.5 h workweek.
Blood Sampling Procedure
The dried blood spot method was used for sampling blood. This
procedure is minimally invasive and considered to be easy to
administer. The nurses pricked their finger with a lancet, and
after removing the first blood drop, they applied a small amount
of blood on four marked circles on Whatman 903 Protein Saver
Snap Apart Cards. To be qualified as a good quality blood sample,
the blood should fill the whole circle and should be drenched
through to the back of the card. After blood collection, the
filter cards were dried in room temperature for 12–24 h, and
then returned to the researchers in sealed plastic bags with silica
gels to prevent humidity. The filter cards were stored at −70◦C
until analysis.
Blood Sample Preparation and Microarray
Analyses
To elute cytokines from the dry blood samples, one circle
(12.5mm) was punched out of the blood card, minced and
put into a 1.5ml Eppendorf tube containing 150 µl 1× PBS.
The Eppendorf tube was placed on gentle shaking for 4 h in
room temperature. The filter paper was removed, and the sample
was centrifuged 13,000 RPM for 3min. Then 80 µl eluate was
pipetted onto the antibody array slide Quantibody R© Human
inflammation Array 1 (RayBiotech, Inc., Norcross, GA, USA)
and analyzed according to the manufacturer’s instructions. After
analysis the antibody array slides were stored at 4◦C and sent
to RayBiotech Life, Inc, USA, for scanning (Innopsys Innoscan
710), data extraction and calculation of the concentration of each
cytokine in pg/ml.
Quantibody R© uses the principle of microarray (forward
phase) and enables the detection of several different proteins.
In the current project, the following immunological biomarkers
were measured: IL-1alpha, IL-1beta, IL-4, IL-6, IL-8, IL-10, IL-
13, MCP-1, IFN-gamma, and TNF-alpha. Table 1 shows the
limit of detection (LOD) (provided by RayBiotech Life) of the
analyses for each immunological parameter. Most proteins, with
the exception of MCP-1, had a high percentage of values below
LOD. However, as the data are epidemiological, we kept all data,
as suggested by Whitcomb and Schisterman (15). In cases were
protein levels were not detected (=0), we substituted 0 with a
random number between 0 and the lowest value detected for
each specific protein. The statistical results remained the same
irrespective of imputation or no imputation.
Questionnaire
We collected data on self-reported sleep duration and sleep
quality the night before blood sampling from a short
questionnaire sent out together with the blood sampling
equipment. Furthermore, we had data from the invitation
questionnaire of the SUSSH cohort. From that questionnaire we
collected information about the nurses’ age, sex, marital status,
work time equivalent, weight, height, work schedule, number of
night shifts worked the last year, and number of quick returns
worked the last year. In addition, presence of shift work disorder
(SWD) was measured with three questions based on the criteria
from the third edition of the International Classification of Sleep
Disorders [ICSD-3; (16)]. The questions were: (a) Do you have a
work schedule that sometimes overlap with the time you usually
sleep?, (b) If yes, does this cause insomnia and/or excessive
sleepiness due to reduced amount of sleep?, (c) If yes, has this
lasted for at least 3 months? Participants were classified as having
SWD if they responded “yes” to all three questions. Body mass
Frontiers in Public Health | www.frontiersin.org 3 September 2020 | Volume 8 | Article 415
Bjorvatn et al. Shift Work and Immunological Biomarkers
TABLE 1 | Statistics of the limit of detection (LOD) for each
immunological biomarker.











IL, interleukin; MCP, monocyte chemoattractant protein; IFN, interferon; TNF, tumor
necrosis factor. Based on samples from 390 nurses.
index was calculated as weight (kg) divided by the square of
height (meters).
Statistics
The statistical analyses were conducted with IBM SPSS Statistics
25 for Windows. Due to positive skewness, all statistical analyses
were conducted with log-transformed cytokine values. In study 1,
multiple linear regressions were conducted with the different
immunological biomarkers as dependent variables, and with
adjustment for age, sex, and body mass index [since these
variables are shown to influence cytokine levels (17)]. Predictors
were work schedule [day only (reference), two-shift rotation,
three-shift rotation], number of night shifts during the last year
[0 (reference), 1–30, >30], number of quick returns during the
last year [0 (reference), 1–30, >30], sleep duration [<6 h, 6–
7.9 h (reference), 8+ h], sleep quality [very good/pretty good
(reference), indifferent/pretty bad/very bad], and shift work
disorder [no (reference), yes]. In study 2, one-way ANOVAs
for repeated measures (Wilks’ Lambda) with post-hoc LSD tests
and effect sizes (multivariate partial eta squared in which 0.01,
0.06, and 0.14 suggest small, moderate, and large effect sizes,
respectively) were used to compare intra-individual values of the
different immunological biomarkers after a night of sleep, after a
day shift, and after a night shift. Significance level was set to 0.05.
Ethics
The study was approved by the Regional Committee for Medical
and Health Research Ethics of Western Norway (REK-West, no
088.08). Informed consent in written form was obtained from
all participants.
RESULTS
Most of the immunological biomarkers, with the exception of IL-
1beta and MCP-1, were present in very low amounts, and with
a high percentage of values below LOD (Table 1). Histograms
showing the values for the different cytokines are available as a
Supplementary File.
TABLE 2 | Questionnaire data among shift working nurses (n = 390) participating
in study 1.
Mean (SD)
Age (missing = 0) 40.5 (8.5)
Body mass index (BMI) (missing = 2) 25.1 (4.5)
% (n)
Sex (missing = 1)
Female 93.6 (364)
Male 6.4 (25)
Marital status (missing = 1)
Married/cohabiting 76.6 (298)
Single 23.4 (91)





Work schedule (missing = 1)
Day only 27.8 (108)
Day-evening 33.9 (132)
Day-evening-night 38.3 (149)








Sleep durationa (missing = 3)
<6 h 25.6 (99)
6–7.9 h 62.3 (241)
8+ h 12.1 (47)
Sleep qualitya (missing = 3)
Very good/pretty good 69.8 (270)
Indifferent/pretty bad/very bad 30.2 (117)
Shift work disorder (missing = 6)
Yes 33.1 (127)
No 66.9 (257)
aThe night before blood sampling.
The participants in study 1 (n = 390) were on average 40.5
years (SD = 8.5), and 93.6% were females. Other demographic
information as well as data regarding body mass index, work
schedule characteristics, number of night shifts worked the last
year, number of quick returns worked the last year, self-reported
sleep duration and sleep quality, and shift work disorder are
provided in Table 2.
Table 3 presents the levels of the immunological biomarkers
in relation to different groups of the shift working nurses (study
1). In relation to work schedule, day-evening work was associated
with significantly higher levels of IL-1alpha and IL-13 than day
only work (Table 4). In relation to number of nights worked last
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TABLE 3 | Levels of immunological biomarkers in pg/ml after a night of sleep among different groups of shift working nurses (n = 390).
IL-1alpha IL-1beta IL-4 IL-6 IL-8 IL-10 IL-13 MCP-1 IFN-gamma TNF-alpha
Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR Median, IQR
Cytokine levels 3.95, 9.45 4.65, 8.70 0.80, 3.03 0.40, 2.54 0.75, 6.97 0.07, 0.06 0.08, 0.56 174.55, 122.08 0.10, 1.55 0.50, 2.04
Work schedule
Day only 2.50, 9.02 4.15, 7.10 0.50, 2.65 0.30, 2.32 0.30, 5.83 0.07, 0.06 0.08, 0.37 171.00, 132.13 0.10, 1.26 0.30, 1.74
Day-evening 5.10, 9.15 4.55, 8.17 1.10, 3.30 0.70, 2.53 2.15, 7.71 0.08, 0.17 0.10, 0.75 164.70, 129.78 0.25, 1.65 0.65, 2.04
Day-evening-night 3.70, 10.29 4.80, 10.55 0.70, 3.18 0.20, 2.69 0.10, 7.20 0.07, 0.07 0.08, 0.46 184.70, 108.35 0.10, 1.45 0.60, 2.45
NN last year
0 4.20, 9.64 4.00, 7.60 1.00, 3.04 0.50, 2.64 1.10, 6.85 0.07, 0.06 0.08, 0.66 166.00, 129.55 0.20, 1.65 0.40, 2.03
1–30 3.35, 7.43 4.55, 10.03 0.45, 2.23 0.20, 2.29 0.15, 7.98 0.07, 0.07 0.08, 0.57 176.55, 127.83 0.10, 1.06 0.40, 1.60
>30 3.85, 12.16 5.70, 10.77 0.95, 3.44 0.40, 2.62 0.30, 7.33 0.07, 0.06 0.09, 0.46 185.50, 97.28 0.10, 1.67 0.80, 2.87
QR last year
0 2.60, 9.23 3.35, 7.05 0.45, 2.85 0.20, 2.62 0.09, 5.71 0.07, 0.06 0.08, 0.44 164.85, 134.70 0.10, 1.41 0.30, 2.10
1–30 4.40, 9.92 5.30, 12.15 1.00, 2.78 0.40, 2.48 0.20, 7.55 0.07, 0.06 0.09, 0.56 170.60, 114.40 0.10, 1.55 0.40, 2.55
>30 3.95, 9.83 3.85, 8.98 0.85, 3.44 0.40, 2.69 1.35, 7.89 0.07, 0.07 0.09, 0.73 179.20, 128.75 0.10, 1.45 0.70, 1.95
Sleep duration
6.0–<8 h 3.90, 9.52 4.90, 9.60 0.70, 2.69 0.30, 2.49 0.40, 6.85 0.07, 0.06 0.08, 0.46 176.00, 115.55 0.10, 1.45 0.40, 1.99
<6 h 4.40, 9.55 4.00, 10.62 1.00, 3.36 0.60, 3.14 0.40, 7.55 0.07, 0.07 0.08, 0.66 170.60, 132.30 0.30, 1.65 1.10, 3.02
8+ h 3.50, 9.42 4.00, 6.50 1.10, 3.52 0.30, 2.34 1.80, 8.13 0.07, 0.06 0.20, 0.72 154.20, 141.10 0.10, 1.86 0.09, 1.36
Sleep quality
Good 3.65, 9.38 4.40, 7.82 0.75, 2.93 0.30, 2.46 0.55, 7.08 0.07, 0.06 0.08, 0.56 174.85, 120.90 0.10, 1.55 0.40, 2.04
Indifferent/bad 4.40, 9.75 5.50, 11.95 0.90, 3.19 0.60, 2.84 1.80, 6.99 0.07, 0.06 0.10, 0.56 176.90, 119.10 0.20, 1.50 0.70, 2.49
SWD
No 4.30, 9.47 4.80, 8.60 0.80, 2.83 0.40, 2.74 0.70, 7.60 0.07, 0.06 0.08, 0.66 174.50, 124.35 0.10, 1.55 0.50, 1.94
Yes 3.70, 10.23 4.40, 10.40 0.90, 3.74 0.40, 2.14 0.90, 6.44 0.07, 0.07 0.08, 0.46 175.50, 118.00 0.10, 1.56 0.40, 2.15
IL, interleukin; MCP, monocyte chemoattractant protein; IFN, interferon; TNF, tumor necrosis factor; NN, night shifts; QR, quick returns; IQR, interquartile range; SWD, shift work disorder.
year, working more than 30 night shifts last year was associated
with a near-significant higher MCP-1 level than not working
night shifts (Table 4). In relation to number of quick returns
worked last year, nurses working between 1 and 30 quick returns
last year had higher IL-1beta levels, and nurses working more
than 30 quick returns had higher MCP-1 levels in comparison to
not working quick returns (Table 4). In relation to sleep duration
the night before blood sampling, short sleep duration (<6 h)
was associated with lower IL-1beta levels and higher TNF-alpha
levels, in comparison to a sleep duration of 6–7.9 h (Table 4).
Furthermore, long sleep duration (8+ h) was associated with
higher IL-13 levels. In relation to sleep quality the night before
blood sampling and in relation to shift work disorder, no
association to levels of cytokines was found (Table 4).
In study 2 (subset with n = 55), the participants were 39.0
years (SD = 8.1) and 94.4% were females. Table 5 presents the
levels of the immunological biomarkers after a night of sleep,
after a day shift, and after a night shift within the same nurses.
There were significant ANOVAs for IL-1beta, MCP-1 and TNF-
alpha. Partial eta squared indicated large effect sizes for IL-1beta
and MCP-1, and moderate to large effect size for TNF-alpha
(Table 5). Post-hoc tests showed that IL-1beta levels were higher
after a day shift and after a night shift in comparison to levels
after a night of sleep. In contrast, MCP-1 levels were lower
after a day shift and after a night shift compared with after a
night of sleep. For TNF-alpha, post-hoc tests showed that the
level was higher after a day shift compared to after a night of
sleep (Table 5).
DISCUSSION
We anticipated (aim of study 1) that there would be differences in
several immunological biomarkers depending on work schedule,
number of night shifts and quick returns, and depending on
sleep duration, sleep quality, and shift work disorder. This
notion was partially supported, as levels of IL-1alpha (work
schedule), IL-1beta (quick returns and sleep duration), IL-13
(work schedule and sleep duration), MCP-1 (number of night
shifts and number of quick returns), and TNF-alpha (sleep
duration) differed between the respective groups. However,
considering the approach to analyzemany biomarkers, the results
may indicate that neither shift work, sleep duration nor sleep
quality strongly affect immunological biomarkers.
The aim of study 2 was to explore whether the measured
immunological biomarkers would differ after a night of sleep
compared with after a day shift and after a night shift –
in a within-subject design. IL-1beta, TNF-alpha, and MCP-1
significantly differed depending on sample occasion. Post-hoc
tests showed higher IL-1beta and TNF-alpha levels after the shifts
(for TNF-alpha only after a day shift) compared with after a
night of sleep, whereas MCP-1 levels were lower after the work
shifts compared to after a night of sleep. Thus, there was no clear
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TABLE 4 | Results from multiple linear regression analyses with different work characteristics, sleep duration, sleep quality, and shift work disorder as predictors, with
adjustment for age, sex, and body mass index.
IL-1alpha IL-1beta IL-4 IL-6 IL-8 IL-10 IL-13 MCP-1 IFN-gamma TNF-alpha
β, p-value β, p-value β, p-value β, p-value β, p-value β, p-value β, p-value β, p-value β, p-value β, p-value
Work schedule
Day only (ref)
Day–evening 0.14, 0.020 0.04, 0.479 0.11, 0.071 0.08, 0.196 0.10, 0.095 0.09, 0.154 0.13, 0.036 0.02, 0.746 0.07, 0.271 0.09, 0.168
Day–evening–night 0.07, 0.272 −0.01, 0.823 0.05, 0.438 −0.00, 0.946 −0.02, 0.813 0.01, 0.821 0.03, 0.625 0.08, 0.184 −0.01, 0.879 0.06, 0.345
NN last year
0 (ref)
1–30 −0.05, 0.347 0.01, 0.895 −0.04, 0.467 −0.02, 0.707 −0.05, 0.319 −0.06, 0.272 −0.07, 0.176 0.07, 0.168 −0.09, 0.104 −0.05, 0.362
>30 0.02, 0.726 −0.02, 0.687 0.01, 0.829 −0.04, 0.473 −0.04, 0.456 −0.04, 0.462 −0.03, 0.635 0.10, 0.051 −0.03, 0.635 0.05, 0.388
QR last year
0 (ref)
1–30 0.11, 0.110 0.14, 0.034 0.05, 0.451 0.02, 0.751 0.04, 0.543 0.03, 0.670 0.00, 0.982 0.09, 0.177 −0.00, 0.962 0.00, 0.983
>30 0.09, 0.191 0.02, 0.725 0.07, 0.264 0.04, 0.559 0.10, 0.143 0.04, 0.519 0.07, 0.282 0.13, 0.043 0.02, 0.787 0.02, 0.743
Sleep duration
6.0–<8 h (ref)
<6 h 0.01, 0.890 −0.11, 0.041 0.04, 0.430 0.03, 0.573 0.01, 0.856 0.02, 0.693 0.00, 0.987 −0.03, 0.615 0.04, 0.493 0.11, 0.040
8+ h 0.00, 0.940 −0.02, 0.679 0.08, 0.144 0.02, 0.702 0.07, 0.178 0.04, 0.407 0.11, 0.030 −0.05, 0.367 0.03, 0.638 −0.06, 0.232
Sleep quality
Good (ref)
Indifferent/bad 0.07, 0.172 0.00, 0.938 0.03, 0.507 0.02, 0.770 0.03, 0.532 0.02, 0.654 0.04, 0.429 −0.03, 0.584 0.01, 0.840 0.07, 0.165
SWD
No (ref)
Yes 0.01, 0.929 −0.04, 0.492 0.01, 0.858 −0.02, 0.652 −0.02, 0.663 −0.06, 0.287 −0.03, 0.531 −0.02, 0.655 −0.05, 0.298 −0.01, 0.790
IL, interleukin; MCP, monocyte chemoattractant protein; IFN, interferon; TNF, tumor necrosis factor; NN, night shifts; QR, quick returns; Ref, reference group; SWD, shift work disorder;
β, standardized beta. Significant findings in bold. All regressions were conducted with log-transformed cytokine values due to positive skewness.
influence on the majority of these immunological biomarkers
depending on whether the blood sample was taken after sleep
or after work periods. It is important to note that the blood
samples taken after the day shift and after the night shift were
non-fasting, as compared to the fasting blood sample taken after
a night of sleep. How this may have affected the results is unclear.
Also, diurnal influences may have impacted the results. However,
there is poor understanding of the diurnal variation of most
cytokines (2, 18, 19). Most evidence concerns IL-6 where a recent
meta-analysis showed levels to be lower in the morning (20).
Unfortunately, in the present studymost IL-6 data were under the
LOD and we could not make any clear conclusions as to whether
shift workers suffered from a systemic inflammation with regard
to IL-6 or whether there was an alteration seen after a night shift.
With respect to the previous literature on how shift work and
sleep relate to cytokines, our findings are partially in contrast with
several previous studies (5, 7, 8, 12, 21) but in agreement with
others (6, 10, 11). In a systematic review andmeta-analysis on the
link between sleep disturbance, sleep duration and inflammation,
Irwin et al. (3) found 72 studies assessing IL-6, TNF-alpha,
and C-reactive protein (CRP). It was reported that TNF-alpha
was not associated with neither sleep disturbances nor sleep
duration, whereas IL-6 was associated with sleep disturbance
(higher values) but not short sleep duration, partially lending
support to the present findings. Irwin et al. (3) also reported
that sleep disturbance and short sleep duration were associated
with higher levels of CRP, however, that inflammatory biomarker
was not measured in the present study. Furthermore, neither
experimental sleep deprivation nor sleep restriction have been
found to be associated with IL-6, TNF-alpha, or CRP (3). The
authors concluded that sleep disturbance, but not short sleep
duration, was associated with higher levels of markers of systemic
inflammation (3). In another systematic review, it was concluded
that acute or chronic sleep loss do not influence levels of IL-4
and IL-10 (4). In the present study, short sleep duration (<6 h)
was associated with lower IL-1beta levels and higher TNF-alpha
levels, whereas long sleep duration (8+ h) was associated with
higher IL-13 levels. However, we found no association between
the immunological biomarkers and sleep quality or shift work
disorder. Our findings therefore extend current knowledge of
the rather weak associations between shift work, sleep, and
immune functioning.
One of the findings in study 2 was reduced levels of MCP-
1 after a day shift and in the morning after a night shift
compared with morning levels after a night of sleep. MCP-1 is
a chemo-attractant and one of the key cytokines that regulate
migration and infiltration of monocytes and macrophages into
different tissues around the body. It is believed to play a
role in the development of atherosclerosis and probably also
in autoimmune disease (22, 23). Our finding with regard to
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TABLE 5 | Levels of immunological biomarkers in pg/ml after a night of sleep (morning fasting), after a day shift (afternoon not fasting), and after a night shift (morning not







Mean SD Mean SD Mean SD Wilks’ Lamdaa F(2,53) Partial Eta squared
IL-1alpha 4.6 6.4 4.9 5.4 6.4 10.2 0.99, p = 0.68 0.015
IL-1beta 7.2 12.2 8.2** 10.0 12.6** 18.2 0.83, p = 0.007 0.172
IL-4 1.5 2.4 1.0 1.6 1.5 2.8 0.99, p = 0.69 0.014
IL-6 1.1 1.8 1.1 1.8 1.1 1.7 0.97, p = 0.40 0.034
IL-8 4.4 7.4 4.8 7.6 4.5 8.1 0.95, p = 0.26 0.049
IL-10 0.3 0.3 0.2 0.2 0.2 0.3 0.99, p = 0.69 0.014
IL-13 0.3 0.5 0.5 0.9 0.5 1.1 0.98, p = 0.59 0.020
MCP-1 190.9 103.3 149.8** 88.2 167.5* 92.5 0.86, p = 0.02 0.144
IFN-gamma .6 1.0 1.0 1.5 .9 2.1 0.96, p = 0.32 0.042
TNF-alpha 1.0 1.5 1.5* 1.8 1.2 1.7 0.88, p = 0.04 0.118
IL, interleukin; MCP, monocyte chemoattractant protein; IFN, interferon; TNF, tumor necrosis factor; SD, standard deviation. aAnalyses were conducted with log-transformed cytokine
values due to positive skewness.
*p < 0.05 vs. “After sleep” on post-hoc Least Significant Difference (LSD).
**p < 0.01 vs. “After sleep” on post-hoc LSD.
MCP-1 using a within-subject study design is novel. Further
studies are needed to clarify the importance of MCP-1 in
shift work.
Strengths and Limitations
This present project has several limitations and strengths. The
blood spot method allowed the nurses to take samples in
their home environment, thus facilitating blood sampling after
waking up in the morning after sleep. Also, the antibody array
method allowed us to analyze ten different biomarkers from
the same sample, which is considered to be a major strength.
Furthermore, another asset was that we were able to compare
levels of immunological biomarkers at the same time points
(after sleep vs. after night work), as well as compare levels
at different time points (sample taken in the afternoon vs.
morning samples after sleep/after night shift). While participants
may have been measured at different circadian phases—due
to differences between individuals in terms of diurnal type
or alterations within individuals across the work schedule—
the present approach should be seen as pragmatic, in order
to limit influence from the circadian system when frequent
samples covering the entire 24 h window could not be done.
The relatively large group of nurses with acceptable response
rates is also an asset. Furthermore, we believe our assessment
of the exposure to a number of shift work characteristics is a
strength. For example, the number of night shifts and quick
returns are known to contribute to circadian disruption and are
also seen as risk factors for adverse health. Another strength
was that we adjusted for age, sex, and body mass index in the
group comparisons, as these variables are shown to influence
cytokine levels (17). A major limitation with this self-performed
blood sampling procedure was that many of the initial samples
were of poor quality, usually due to blood not covering the
whole circle of the filter cards. Considering that these participants
were nurses who are trained to handle blood, it is to be
expected that such a sampling procedure may be even more
difficult in other populations. Another concern relates to the
low levels of immunological biomarkers in the blood samples.
For all biomarkers except for MCP-1 and IL-1beta, most of the
samples had levels that were below the detection limit. This
is however common when measuring cytokines in circulation
but is clearly a limitation with the chosen method since other
methods are more sensitive with regards to detecting systemic
cytokines, such as IL-6. The definition of limit of detection
(LOD) is the concentration or the quantity that can be detected
with reasonable certainty for a given analytical procedure (15).
To avoid biasing estimates it is recommended to use all data
including those below LOD in epidemiological studies like the
present investigation (15). Also, it is important to note that the
concentration of most cytokines in healthy individuals is very
low and not always detectable even with more sensitive methods
(4). The results are likely to be most robust for the IL-1beta
and MCP-1 findings, since more than 61 and 99% of the values
were above LOD, respectively. For the other cytokines, many
samples were below the lower detection level, and the results
regarding these should therefore be interpreted with caution.
Another limitation with the approach to include many cytokines
is the risk of conducting type-I errors. We did not apply any
corrections to reduce the risk for false positive findings as such
an approach would have reduced the statistical power, hence
increasing the risk of making type-II errors. We believe that
these estimates could give directionality for future studies, e.g., as
priors in a Bayesian statistic. Still, the fact that the cytokine levels
were generally low, suggests that shift work does not strongly
affect immunity. Still, it should be noted that some of the group
comparisons may have been influenced (e.g., comparing day only
to shift worker) by “the healthy shift worker effect” (24). Also,
the day only group included nurses with previous shift work
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experience. How and if thismay have affected the results however,
is unclear.
Based on previous literature and the present findings, one
cannot make strong conclusions regarding how shift work affects
immunity. An important step in solving this issue will be
to merge data from several studies (e.g., by meta-analytical
approaches), increasing the power to make more accurate
estimates of possible effects.
In conclusion, the present findings showed some indications
of shift workers to have higher levels of inflammatory biomarkers.
However, neither work schedule, number of night shifts, number
of quick returns, short sleep duration, poor sleep quality, nor
having shift work disorder seemed to have a major impact on the
levels of a multitude of immunological biomarkers. Yet, levels of
IL-1beta and TNF-alpha were higher after a day shift, levels of
IL-1beta were higher after a night shift, and levels of MCP-1 were
lower both after a day shift and after a night shift, in comparison
with morning levels after a night of sleep, respectively, which
suggests that work may acutely impact immune function.
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